
Eli Lilly Announces Lower-Cost Generic Insulin
Eli Lilly and Company announced it will begin selling a generic version of its most commonly prescribed insulin -- Humalog
Discover stories from Breakthrough T1D about our research, advocacy, initiatives, and supporters.
Read the latest press releases and statements from Breakthrough T1D.
Sign up for Insider News to receive breaking news updates from Breakthrough T1D.